Holder evidence
3
SEC ownership of Nu-Med Plus, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001543637.
Lead holder
Jeffrey L. Robins
13D/G signal
—
Latest evidence
07 Nov 2023
- CIK
- 0001543637
- Symbol
- NUMD on OTC
- Location
- Port Jefferson, NY
- SEC evidence mix
- 3/4/5
- Lead holder
- Jeffrey L. Robins
- Latest evidence date
- 07 Nov 2023
Issuer identity
Ownership snapshot
Ownership snapshot
Top shareholders of Nu-Med Plus, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Lead holder
Jeffrey L. Robins
13D/G signal
—
Evidence rows
3
Latest as of
07 Nov 2023
3/4/5
Highest disclosed value: $98,800
Rank 1 holder
Jeffrey L. Robins
3/4/5
- Ownership
- —
- Position
- $98.8K
Rank 2 holder
Keith L. Merrell
3/4/5
- Ownership
- —
- Position
- $79.4K
Rank 3 holder
William C. Hayde
3/4/5
- Ownership
- —
- Position
- $60.8K
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Jeffrey L. Robins |
3/4/5
Director
|
—
class O/S missing
|
$98,800
5,200,000 shares
|
— | 07 Nov 2023 |
| Keith L. Merrell |
3/4/5
Chief Financial Officer, Director
|
—
class O/S missing
|
$79,444
4,181,250 shares
|
— | 01 Aug 2015 |
| William C. Hayde |
3/4/5
Chief Executive Officer, Director
|
—
class O/S missing
|
$60,800
3,200,000 shares
|
— | 07 Nov 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 31 May 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-3 of 3 reporting-owner rows connected to Nu-Med Plus, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
3
Lead holder
Jeffrey L. Robins
Net 12M change
$0
Latest report
07 Nov 2023
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Jeffrey L. Robins | Director | $98,800 | Mixed | 07 Nov 2023 | ||
| Keith L. Merrell | Chief Financial Officer, Director | $79,444 | Mixed | 01 Aug 2015 | ||
| William C. Hayde | Chief Executive Officer, Director | $60,800 | Mixed | 07 Nov 2023 |
Recent insider transactions for Nu-Med Plus, Inc.
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Reported value | Reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||
* indicates a reported price that failed the local validity check.